Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)


Ramos-Casals M., Maria A., Suarez-Almazor M. E. , Lambotte O., Fisher B. A. , Hernandez-Molina G., ...Daha Fazla

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.37, sa.3, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Konu: 3
  • Basım Tarihi: 2019
  • Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Özet

Objectives: To analyse the worldwide occurrence of sicca/Sjogren's (SS) syndrome associated with the use of immune checkpoint inhibitors (ICI) in patients with cancer.